These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23024705)

  • 1. Dapoxetine: a new option in the medical management of premature ejaculation.
    McMahon CG
    Ther Adv Urol; 2012 Oct; 4(5):233-51. PubMed ID: 23024705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of dapoxetine in the treatment of premature ejaculation.
    McMahon CG
    Clin Med Insights Reprod Health; 2011 Aug; 5():25-39. PubMed ID: 24453509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapoxetine for premature ejaculation.
    McMahon CG
    Expert Opin Pharmacother; 2010 Jul; 11(10):1741-52. PubMed ID: 20540653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.
    McMahon CG; Giuliano F; Dean J; Hellstrom WJ; Bull S; Tesfaye F; Sharma O; Rivas DA; Aquilina JW
    J Sex Med; 2013 Sep; 10(9):2312-25. PubMed ID: 23845016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials.
    McMahon CG; Althof SE; Kaufman JM; Buvat J; Levine SB; Aquilina JW; Tesfaye F; Rothman M; Rivas DA; Porst H
    J Sex Med; 2011 Feb; 8(2):524-39. PubMed ID: 21059176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine.
    McMahon C; Kim SW; Park NC; Chang CP; Rivas D; Tesfaye F; Rothman M; Aquilina J;
    J Sex Med; 2010 Jan; 7(1 Pt 1):256-68. PubMed ID: 19878447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries.
    Buvat J; Tesfaye F; Rothman M; Rivas DA; Giuliano F
    Eur Urol; 2009 Apr; 55(4):957-67. PubMed ID: 19195772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case.
    Waldinger MD; Schweitzer DH
    J Sex Med; 2008 Apr; 5(4):966-997. PubMed ID: 18371047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation.
    McMahon CG; Porst H
    J Sex Med; 2011 Oct; 8(10):2707-25. PubMed ID: 21771283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of dapoxetine in treatment of premature ejaculation: an evidence-based review.
    Russo A; Capogrosso P; Ventimiglia E; La Croce G; Boeri L; Montorsi F; Salonia A
    Int J Clin Pract; 2016 Sep; 70(9):723-33. PubMed ID: 27456527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging treatments for premature ejaculation: focus on dapoxetine.
    Hellstrom WJ
    Neuropsychiatr Dis Treat; 2009; 5():37-46. PubMed ID: 19557098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation: prospective, randomized, double-blind, placebo-controlled, multicenter study.
    Lee WK; Lee SH; Cho ST; Lee YS; Oh CY; Yoo C; Cho JS; Lee SK; Yang DY
    J Sex Med; 2013 Nov; 10(11):2832-41. PubMed ID: 23937271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial.
    Kaufman JM; Rosen RC; Mudumbi RV; Tesfaye F; Hashmonay R; Rivas D
    BJU Int; 2009 Mar; 103(5):651-8. PubMed ID: 19021601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine.
    Shabsigh R; Patrick DL; Rowland DL; Bull SA; Tesfaye F; Rothman M
    BJU Int; 2008 Sep; 102(7):824-8. PubMed ID: 18647300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapoxetine for premature ejaculation: an updated meta-analysis of randomized controlled trials.
    Li J; Yuan H; Bai Y; Pu C; Tang Y; Dong Q; Wei Q; Han P
    Clin Ther; 2014 Dec; 36(12):2003-2014. PubMed ID: 25438723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.
    Hutchinson K; Cruickshank K; Wylie K
    Drug Saf; 2012 May; 35(5):359-72. PubMed ID: 22452563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation.
    McCarty E; Dinsmore W
    Core Evid; 2012; 7():1-14. PubMed ID: 22315582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials.
    Pryor JL; Althof SE; Steidle C; Rosen RC; Hellstrom WJ; Shabsigh R; Miloslavsky M; Kell S;
    Lancet; 2006 Sep; 368(9539):929-37. PubMed ID: 16962882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of 'on demand' silodosin in the treatment of premature ejaculation in patients dissatisfied with dapoxetine: a randomized control study.
    Bhat GS; Shastry A
    Cent European J Urol; 2016; 69(3):280-284. PubMed ID: 27729995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety of dapoxetine in the treatment of premature ejaculation].
    Chen XY; Qu YW; Wang SG
    Zhonghua Nan Ke Xue; 2016 May; 22(5):411-4. PubMed ID: 27416664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.